DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 1.87% to $144.74 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.73% to 7,722.72 and the Dow Jones Industrial Average rising 0.49% to 51,176.96.
This was the stock's fourth consecutive day of losses.
Gilead Sciences Inc. closed 7.98% below its 52-week high of $157.29, which the company achieved on February 11th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 1.02% to $256.03, Pfizer Inc. $(PFE)$ fell 1.14% to $27.80, and Abbott Laboratories $(ABT)$ rose 0.84% to $97.50.
Trading volume (4.8 M) remained 1.3 million below its 50-day average volume of 6.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.